Assessment of the impact of procurement centralization on the drug provision for patients within the High-Cost Nosology Program in the Russian Federation
Background. In the Russian Federation, patients receive expensive drugs from the federal budget funds within High-Cost Nosology (HCN) Program.Objective: to assess the impact of drug procurement centralization on the weighted average price (WAP) per 1 unit of measurement (UM) of a drug, the procureme...
Saved in:
Main Authors: | V. V. Omelyanovskiy, V. A. Ryagina, A. G. Kharitonova, K. I. Matrenin, A. A. Kingshott, O. V. Ashikhmina, M. V. Zhirov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2024-11-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/1089 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of actual results of drug supply implementation within framework of High-Cost Nosologies Program
by: O. I. Ivakhnenko, et al.
Published: (2024-05-01) -
Peculiarities of administration of medications to patients with circulatory system diseases within the framework of the federal program of preferential provision of medicines
by: I. K. Petrukhina, et al.
Published: (2021-10-01) -
Dynamics of anticancer drug use in Russian hospitals: a five-year retrospective analysis
by: J. A. Agafonova, et al.
Published: (2025-02-01) -
Analysis of the strategy of drug provision of certain categories of the population of the krasnodar region
by: V. V. Pilshchikova, et al.
Published: (2021-11-01) -
Awareness of doctors and epilepsy patients about preferential drug provision
by: A. S. Romanov, et al.
Published: (2023-07-01)